Brimo PS DDS®
190342-033D
Phase 2 small_molecule completed
Quick answer
Brimo PS DDS® for Patients Who Participated in an Intravitreal Brimo PS DDS® Study is a Phase 2 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Patients Who Participated in an Intravitreal Brimo PS DDS® Study
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed